Prof. Dr. Marc Stadler is a professor at the TU Braunschweig, where he has been researching at the HZI since 2012 and where he teaches courses in biology and biotechnology. He studied biology at the Technical University of Kaiserslautern and received his doctorate in biotechnology in 1993 on new active ingredients from predatory fungi with a scholarship from the German National Academic Foundation. After a DFG-funded postdoc period at the Swedish University of Lund in the field of natural product chemistry, he switched to industry in 1995 and worked in pharmaceutical research at Bayer Healthcare. In 2006, together with other Bayer researchers, he founded InterMed Discovery GmbH, where he worked as a department head until April 2012. During his 17 years in the industry, he was responsible for fungal and microbial strain collections, biotechnological process development, and a natural chemical laboratory. At the same time, he habilitated at the University of Bayreuth in the field of mycology. As a globally recognized expert in industrial microbiology and mycology and fungal biodiversity research, he is a member of the Editorial Boards of leading mycological journals such as Studies in Mycology and Fungal Diversity. In 2021, he was elected the next President of the International Mycological Association (IMA). His research interests include mycology, natural products, biotechnology, taxonomy, phylogeny, chromatography, fermentation, and microbiology.